SCHEMBL9891650

SCHEMBL9891650

CCCCOc1ccc(CF)cc1CCC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.42
PPARD Q03181 5/20 0.41
PPARA Q07869 5/20 0.41
LTB4R Q15722 1/20 0.40
PTGES O14684 2/20 0.40
ALOX5 P09917 2/20 0.40
AKR1C3 P42330 1/20 0.39
HTT P42858 3/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 2/20 0.38
PLA2G2D Q9UNK4 1/20 0.38
APAF1 O14727 1/20 0.38
THRB P10828 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9891651 0.89 LTB4R (0.41) PPARGPPARDPPARALTB4RPTGES
SCHEMBL12704384 0.86 PPARG (0.39) PPARGPPARDPPARALTB4RPTGES
SCHEMBL9889129 0.83 PTGER1 (0.49) AKR1C3MTNR1AMTNR1BITGB1ITGA4
SCHEMBL9889095 0.78 MTNR1A (0.40) PPARDPPARAMTNR1AMTNR1BITGB1
SCHEMBL9889103 0.72 PTGER1 (0.50) AKR1C3HTTMAPTMTNR1AMTNR1B
SCHEMBL8036310 0.72 MTNR1A (0.40) MTNR1AMTNR1B
SCHEMBL2542877 0.70 LTB4R (0.62) PPARGPPARALTB4RHTTMAPT
SCHEMBL16306929 0.69 SMN1; SMN2 (0.51) PPARGPPARDPPARALTB4RHTT
SCHEMBL19792614 0.69 FFAR4 (0.46) MEN1KMT2A
SCHEMBL7198061 0.69 LTB4R (0.47) PPARGLTB4RPTGESALOX5HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150369816-A1 Polypeptide Immobilization UNIV CHICAGO (US) 2015-12-24 US disclosed
US-9074300-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2015-07-07 US disclosed
EP-1552305-B1 POLYPEPTIDE IMMOBILIZATION UNIV CHICAGO (US) 2013-07-31 EP disclosed
US-20120142547-A1 POLYPEPTIDE IMMOBILIZATION THE UNIVERSITY OF CHICAGO 2012-06-07 US disclosed
EP-2311939-A1 Polypeptide immobilization The University of Chicago (US) 2011-04-20 EP disclosed
US-7888055-B2 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity THE UNIVERSITY OF CHICAGO (US) 2011-02-15 US disclosed
US-20080064606-A1 Polypeptide immobilization THE UNIVERSITY OF CHICAGO 2008-03-13 US disclosed
US-7172905-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2007-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064606-A1 Polypeptide immobilization QPCTL, SURF4, QPCT PPARG 1687/4885PPARD 1506/4885PPARA 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.